Nateglinide Tablet, Film Coated
FDA Label NDC 70771-1015

1 label section · Submitted to the FDA by Zydus Lifesciences Limited · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Zydus Lifesciences Limited for the product Nateglinide (NDC 70771-1015). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Package Label.Principal Display Panel

NDC 70771-1015-9 in bottle of 90 tablets

Nateglinide Tablets USP, 60 mg

Rx only

90 tablets

Nateglinide Tabs 60 mg (Aae47d35 2df3 4dd8 B34e Ac7367650bbe 01)

Nateglinide Tabs 60 mg (Aae47d35 2df3 4dd8 B34e Ac7367650bbe 01)

NDC 70771-1016-9 in bottle of 90 tablets

Nateglinide Tablets USP, 120 mg

Rx only

90 tablets

Nateglinide Tabs 120 mg (Aae47d35 2df3 4dd8 B34e Ac7367650bbe 02)

Nateglinide Tabs 120 mg (Aae47d35 2df3 4dd8 B34e Ac7367650bbe 02)

* Please review the disclaimer below.